"Merck & Co. sales personnel, using projects code-named 'Offense' and 'XXceleration,' took extensive measures to boost sales of the painkiller Vioxx amid brewing safety concerns.
Documents released Thursday at a congressional hearing detail how a sales army of 3,000 turned the drug into a multibillion-dollar blockbuster before it was pulled from the market last fall because of an increased risk of heart attack and stroke." [NewsFactor.com]
